Triptolide (PG-490) induces apoptosis of dendritic cells through sequential p38 MAP kinase phosphorylation and caspase 3 activation
- 2 July 2004
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 319 (3), 980-986
- https://doi.org/10.1016/j.bbrc.2004.04.201
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-κB activationExperimental & Molecular Medicine, 2002
- IMMUNOSUPPRESSIVE ACTIVITY OF THE CHINESE MEDICINAL PLANT TRIPTERYGIUM WILFORDIITransplantation, 2000
- How can dendritic cells cause autoimmune disease?Immunology Today, 2000
- Dendritic Cells in Cancer ImmunotherapyAnnual Review of Immunology, 2000
- Triptolide is more effective in preventing T cell proliferation and interferon-gamma production than is FK506Phytotherapy Research, 1999
- Are dendritic cells the key to liver transplant tolerance?Immunology Today, 1999
- High-Performance Liquid Chromatographic Determination of Triptonide, Triptriolide, and Triptophenolide in Ethyl Acetate Extract of Tripterygium Wilfordii Hook FJournal of Liquid Chromatography & Related Technologies, 1998
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995
- Effect of an Extract of the Chinese Herbal Remedy Tripterygium Wilfordii Hook F on Human Immune ResponsivenessArthritis & Rheumatism, 1991
- Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells.The Journal of Experimental Medicine, 1982